Lexavon (Levofloxacin Hemihydrate)

Levofloxacin works by binding to bacterial DNA gyrase and topoisomerase IV, enzymes that are essential for DNA replication and transcription. Inhibiting these enzymes stops bacterial cell division, leading to bacterial death and clearance of the infection in the treated eye.

The dosage and frequency of Lexavon are determined by the prescribing clinician based on the specific infection, severity, and patient factors. The prescriber will provide detailed instructions on how many drops to instill and how often they should be applied.

Safety of levofloxacin ophthalmic use during pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by the treating physician.

To order Lexavon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lexavon (levofloxacin) offers broad‑spectrum coverage against Gram‑positive and Gram‑negative ocular pathogens and has a favorable penetration profile in corneal tissue. Compared with older agents such as ciprofloxacin, levofloxacin often requires fewer daily administrations and may have a lower risk of resistance development.

Lexavon should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed when not in use and retain it in its original packaging to protect the solution from contamination.

Lexavon is applied as eye drops directly onto the affected eye(s) according to the prescriber's directions. Typically, the patient tilts the head back, pulls down the lower eyelid to create a pocket, instills the prescribed number of drops, and gently closes the eye for a few seconds. Contact lenses should be removed unless otherwise instructed.

Serious adverse events, although rare, include corneal ulceration, severe allergic reactions such as swelling or rash, and systemic hypersensitivity syndromes like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience worsening pain, vision changes, or signs of a severe reaction.

Lexavon should not be used by individuals with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. It is also contraindicated in patients with active viral or fungal eye infections, as the drug does not treat these conditions.